FDA Approved: LEVOFLOXACIN — Supplemental Application (Sagent Pharmaceuticals)

View source ↗

Summary

The FDA approved a supplemental application for Levofloxacin submitted by Sagent Pharmaceuticals, approving changes to the generic labeling under the ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Sinusitis
• Bronchitis
• Pneumonia
• Pyelonephritis
• Skin and Skin Structure Infection
• Urinary Tract Infection

Drugs mentioned

• Levofloxacin (Levofloxacin)

Snippet

SUPPL AP for LEVOFLOXACIN (LEVOFLOXACIN)